Perspective Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.87

0.00 (-0.14%)

As of Nov 7, 2:01 AM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 19 90%

Hold 2 10%

Sell 0 0%

Price Target

Analyst Price Target +2,163.5% upside

Low Target $12.33

Average Target $19.67

High Target $23.14

Current Price $0.87

Current
$0.87

Target
$19.67

$12.33 $19.67 avg $23.14

Scenario Analysis

Bear Case

$12.33

1,318.9%

Low target

Base Case

$19.67

+2,163.5%

Avg target

Bull Case

$23.14

+2,562.8%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$6.16

-85.9% from high

52-Week Low

$0.84

+3.8% from low

Target vs 52W High

$19.67

+219.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-11.6%
AMGN Amgen Inc	Hold	42	43%	$190.87	-58.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+117.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-19.9%
MRNA Moderna Inc	Hold	31	35%	$149.45	-41.2%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-91.5%
NTRA Natera Inc	Strong Buy	30	90%	$142.91	-54.0%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-40.7%